Vol 61, No 9 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28
Get Citation

Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes

Dariusz Dudek, Waldemar Mielecki, Marcin Wizimirski, Tomasz Rakowski, Artur Dziewierz, Danuta Sorysz, Marek Tomala, Cafer Zorkun, Krzysztof Żmudka, Jacek Dubiel
Kardiol Pol 2004;61(9):238-241.
Vol 61, No 9 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28

Abstract

Background: Subjects with diabetes constitute 13-25% of patients with ST segment elevation acute myocardial infarction (STEMI). In spite of the introduction of thrombolytic therapy, patients with STEMI and diabetes continue to have worse prognosis than those without diabetes. Primary percutaneous coronary intervention (PCI) has been shown in recent years to be the most effective therapy in patients with STEMI.
Aim: To compare the outcome of STEMI patients with or without diabetes who underwent primary PCI.
Methods: The study group consisted of 500 consecutive patients with STEMI. The occurrence of major adverse cardiac events (MACE) which included death, reinfarction or repeated PCI of the target vessel, was analysed peri-operatively and during a six-month follow-up period.
Results: Diabetes was diagnosed in 68 (13.6%) patients. The mean time duration from the onset of STEMI symptoms to treatment was similar in patients with or without diabetes (230±97 min vs 231±139 min, NS). Patients with diabetes were older (61.9±8.9 vs 57.9±10.8 years, p=0.004), had higher body mass index (29±4 vs 27±5, p=0.002), more frequent history of coronary artery disease (57.4% vs 37.9%, p=0.002), higher prevalence of arterial hypertension (71.6% vs 56.8%, p=0.02) and more frequently the left anterior descending artery as the infarct-related artery (58.8% vs 42.1%, p=0.01). Immediately after PCI, epicardial and myocardial reperfusion rates were lower in patients with rather than without diabetes (TIMI 3: 84.9% vs 91.3%, p=NS, cTFC: 32±26 vs 22±16, p

Abstract

Background: Subjects with diabetes constitute 13-25% of patients with ST segment elevation acute myocardial infarction (STEMI). In spite of the introduction of thrombolytic therapy, patients with STEMI and diabetes continue to have worse prognosis than those without diabetes. Primary percutaneous coronary intervention (PCI) has been shown in recent years to be the most effective therapy in patients with STEMI.
Aim: To compare the outcome of STEMI patients with or without diabetes who underwent primary PCI.
Methods: The study group consisted of 500 consecutive patients with STEMI. The occurrence of major adverse cardiac events (MACE) which included death, reinfarction or repeated PCI of the target vessel, was analysed peri-operatively and during a six-month follow-up period.
Results: Diabetes was diagnosed in 68 (13.6%) patients. The mean time duration from the onset of STEMI symptoms to treatment was similar in patients with or without diabetes (230±97 min vs 231±139 min, NS). Patients with diabetes were older (61.9±8.9 vs 57.9±10.8 years, p=0.004), had higher body mass index (29±4 vs 27±5, p=0.002), more frequent history of coronary artery disease (57.4% vs 37.9%, p=0.002), higher prevalence of arterial hypertension (71.6% vs 56.8%, p=0.02) and more frequently the left anterior descending artery as the infarct-related artery (58.8% vs 42.1%, p=0.01). Immediately after PCI, epicardial and myocardial reperfusion rates were lower in patients with rather than without diabetes (TIMI 3: 84.9% vs 91.3%, p=NS, cTFC: 32±26 vs 22±16, p
Get Citation

Keywords

percutaneous coronary intervention - acute myocardial infarction - diabetes

About this article
Title

Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 61, No 9 (2004)

Pages

238-241

Published online

2005-12-12

Bibliographic record

Kardiol Pol 2004;61(9):238-241.

Keywords

percutaneous coronary intervention - acute myocardial infarction - diabetes

Authors

Dariusz Dudek
Waldemar Mielecki
Marcin Wizimirski
Tomasz Rakowski
Artur Dziewierz
Danuta Sorysz
Marek Tomala
Cafer Zorkun
Krzysztof Żmudka
Jacek Dubiel

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl